Karamjeet Singh Sandhu MD
Hematologic Oncology, Hemophilia & Bleeding Disorder, Myeloproliferative Disorder Hematology-Oncology
Assistant Professor
Join to view full profile
1500 Duarte RdDept of Hematology Hematopoietic Cell TransplantationDuarte, CA 91010
Phone+1 626-256-4673
Fax+1 626-301-8116
Dr. Sandhu is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2012 - 2015
Hennepin HealthcareResidency, Internal Medicine, 2009 - 2012
Tver State Medical AcademyClass of 2000
Certifications & Licensure
CA State Medical License 2014 - 2026
MN State Medical License 2014 - 2016
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification Sunrise Acute Care, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts FollowMyHealth, Allscripts, 2016-2017
Clinical Trials
- Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant Start of enrollment: 2021 Apr 30
Roles: Principal Investigator, Contact
- Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML Start of enrollment: 2021 Nov 24
Roles: Contact
- Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation Start of enrollment: 2023 Sep 18
Roles: Contact
Publications & Presentations
PubMed
- to: "Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/ refract...Elias Jabbour, Karamjeet S Sandhu, Paul Shaughnessy, Aaron C Logan, Mehrdad Abedi
Haematologica. 2026-08-01 - Hypomethylating agents-venetoclax as salvage therapy for relapse of AML and MDS after allogeneic HCT.Diana T Samuels, Brian J Ball, Ni-Chun Tsai, Salman Otoukesh, Shukaib Arslan
Blood Neoplasia. 2026-08-01 - Clinical Implications of CD19-Negative Relapse Following CD19-Directed Therapy in B-Cell Acute Lymphoblastic Leukemia.Tamer Othman, Vaibhav Agrawal, Joo Y Song, Zhaohui Gu, Paul Koller
American Journal of Hematology. 2026-07-23
Abstracts/Posters
- The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host DiseaseKaramjeet S. Sandhu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Optimization of Tacrolimus Serum Levels When Combined with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Hematopoietic Cell Transplan...Karamjeet S. Sandhu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
City of Hope Doctors Present New Research on Cancer ImmunotherapiesNovember 4th, 2021- Initial Patient Dosed in Phase 2a Clinical Trial Evaluating First-in-Class Human Milk-Based Therapy in Patients Undergoing Stem Cell Transplantation for Blood CancersNovember 15th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
